Work with thought leaders and academic experts in infectious diseases

Companies can greatly benefit from collaborating with academic researchers in the field of Infectious Diseases. Here are some reasons why:

Researchers on NotedSource with backgrounds in infectious diseases include Michael W Harman, Regan Hamel, Aayudh Das, Ph.D., Mohammad Imran Khan, Dr. David Siderovski, Ph.D., Garrett A. Perchetti, Research Scientist - Virology, Dr. Andrew Bernard, Ph.D., Jeffrey Townsend, Samuel Ojima Adejoh, Liam D. Hendrikse, Ph.D., Abbas Alameer, Naveen Adusumilli, Javier O. Morales, and Odion Ikhimiukor.

Michael W Harman

East Greenwich, RI, Rhode Island, United States of America
Distinguished Subject Matter Expert & Leader in Medical Technologies.
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (13)
Bacteria & Cell Bio-Physics
Biomechanics
Immunology
Microbiology
Parasitology
And 8 more
About
Highly skilled, energetic, and motivated professional empowered by over a decade of cross-disciplinary engineering and scientific applications experience. Presenting elegant solutions to prevalent biomedical challenges. Motivated by driving deliverable outcomes from complex research studies through effective leadership, active consulting work, and innovative problem-solving techniques. Seeking to make an immediate impact in a fast-paced biotechnology environment capitalizing on my advanced comprehension, continued professional growth, strategic product development expertise, and active network of personal connections across all areas of science, engineering, medicine, manufacturing and healthcare.
Most Relevant Publications (1+)

15 total publications

The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks

Infection and Immunity / Aug 01, 2011

Caimano, M. J., Kenedy, M. R., Kairu, T., Desrosiers, D. C., Harman, M., Dunham-Ems, S., Akins, D. R., Pal, U., & Radolf, J. D. (2011). The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks. Infection and Immunity, 79(8), 3117–3130. https://doi.org/10.1128/iai.05136-11

See Full Profile

Aayudh Das, Ph.D.

Boston, Massachusetts, United States of America
Scientist at Garuda therapeutics, specialized in Genomics and Computational Biology
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (14)
Transcriptomics
Genomics
Proteomics
Computational Biology
Metabolomics
And 9 more
About
I am a dedicated Scientist-I at Garuda Therapeutics, where I specialize in computational biology and genomics within the R&D department. My work primarily revolves around developing and optimizing pipelines for variant calling using Strelka2 and GATK4 with Whole Genome Sequencing (WGS) to identify oncogenes in human induced pluripotent stem cells (iPSCs). This involves extensive work in the qualification and validation of these pipelines for regulatory filings, as well as leveraging databases such as ClinVar, COSMIC, and DepMap to craft targeted oncogenes panels for deep sequencing. I also apply Next-Generation Sequencing (NGS) for downstream sequencing to validate CRISPR knockouts, including the identification and validation of CRISPR off-targets using techniques like rhAMPseq and Induce-seq. Additionally, my expertise extends to single-cell sequencing analysis and understanding structural variants with Optical Genome Mapping (Bionano). Prior to joining Garuda Therapeutics, I completed a postdoctoral fellowship in computational biology at Pennsylvania State University, where I honed my skills in identifying climate-adaptive variants and conducted Genome-Wide Association Studies (GWAS) to uncover resistance genes against parasites and other stressors. My academic journey began at the University of Vermont, where I explored abiotic stress resistance genes using transcriptomics and developed a robust understanding of RNA-seq data analysis, from assembly to gene annotation. My work is driven by a passion for leveraging computational and genomics tools to address pressing challenges in biology and healthcare, combining my rigorous academic training with a practical, solution-oriented approach to research and development.
Most Relevant Publications (1+)

10 total publications

A Quantitative Proteomics View on the Function of Qfhb1, a Major QTL for Fusarium Head Blight Resistance in Wheat

Pathogens / Jun 22, 2018

Eldakak, M., Das, A., Zhuang, Y., Rohila, J., Glover, K., & Yen, Y. (2018). A Quantitative Proteomics View on the Function of Qfhb1, a Major QTL for Fusarium Head Blight Resistance in Wheat. Pathogens, 7(3), 58. https://doi.org/10.3390/pathogens7030058

See Full Profile

Dr. David Siderovski, Ph.D.

Fort Worth
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (25)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Molecular Medicine
And 20 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.
Most Relevant Publications (1+)

94 total publications

The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy

Immunity / Jun 01, 2012

Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K.-W., Damania, B., Moore, C. B., Giguère, P. M., Siderovski, D. P., Hiscott, J., Razani, B., Semenkovich, C. F., Chen, X., & Ting, J. P.-Y. (2012). The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy. Immunity, 36(6), 933–946. https://doi.org/10.1016/j.immuni.2012.03.025

See Full Profile

Garrett A. Perchetti, Research Scientist - Virology

New York
Research Scientist and MD Candidate in virology with publications on infectious diseases, laboratory medicine, viral genetics, and clinical medicine
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (14)
Virology
Microbiology
SARS-CoV-2
COVID-19
Microbiology (medical)
And 9 more
About
Garrett A. Perchetti is a highly accomplished research scientist in the field of virology. He received a Bachelor of Science in Microbiology and a Bachelor of Arts in Art History from the University of Washington. His interest in both science and the arts led him to pursue a career in virology, where he could combine his passion for understanding the natural world with his creative thinking skills. After completing his undergraduate studies, Garrett continued his education by earning a Medical Degree from Ross University School of Medicine in 2025. During his time in medical school, he developed a keen interest in virology and infectious diseases, which ultimately led him to specialize in this field. Garrett's educational background is complemented by his extensive experience as a research scientist. He has worked at the University of Washington School of Medicine, where he has conducted groundbreaking research on various types of viruses. His work has been published in numerous scientific journals, and he has presented his findings at international conferences. Garrett's contributions to the field of virology have been widely recognized, and he has received several awards and accolades for his work. He is known for his meticulous attention to detail, innovative thinking, and ability to collaborate effectively with other researchers. In his free time, Garrett enjoys painting, hiking, and traveling. He is also passionate about raising awareness about the importance of vaccinations and promoting public health initiatives. With his exceptional education and extensive experience, Garrett A. Perchetti is a valuable asset to the field of virology and will continue to make significant contributions in the future.
Most Relevant Publications (12+)

28 total publications

Validation of SARS-CoV-2 detection across multiple specimen types

Journal of Clinical Virology / Jul 01, 2020

Perchetti, G. A., Nalla, A. K., Huang, M.-L., Zhu, H., Wei, Y., Stensland, L., Loprieno, M. A., Jerome, K. R., & Greninger, A. L. (2020). Validation of SARS-CoV-2 detection across multiple specimen types. Journal of Clinical Virology, 128, 104438. https://doi.org/10.1016/j.jcv.2020.104438

20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis

Open Forum Infectious Diseases / Nov 01, 2021

Zamora, D., Perchetti, G., Biernacki, M., Xie, H., Castor, J. L., Joncas-schronce, L., Blazevic, R., Leisenring, W., Huang, M.-L., Jerome, K., Martin, P. J., Boeckh, M., & Greninger, A. L. (2021). 20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis. Open Forum Infectious Diseases, 8(Supplement_1), S13–S14. https://doi.org/10.1093/ofid/ofab466.020

Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)

Journal of Clinical Virology / Sep 01, 2022

Mills, M. G., Hajian, P., Bakhash, S. M., Xie, H., Mantzke, D., Zhu, H., Perchetti, G. A., Huang, M.-L., Pepper, G., Jerome, K. R., Roychoudhury, P., & Greninger, A. L. (2022). Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR). Journal of Clinical Virology, 154, 105218. https://doi.org/10.1016/j.jcv.2022.105218

Specific allelic discrimination of N501Y and other SARS‐CoV‐2 mutations by ddPCR detects B.1.1.7 lineage in Washington State

Journal of Medical Virology / Jul 03, 2021

Perchetti, G. A., Zhu, H., Mills, M. G., Shrestha, L., Wagner, C., Bakhash, S. M., Lin, M. J., Xie, H., Huang, M., Mathias, P., Bedford, T., Jerome, K. R., Greninger, A. L., & Roychoudhury, P. (2021). Specific allelic discrimination of N501Y and other SARS‐CoV‐2 mutations by ddPCR detects B.1.1.7 lineage in Washington State. Journal of Medical Virology, 93(10), 5931–5941. Portico. https://doi.org/10.1002/jmv.27155

A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance

Journal of Clinical Virology / Aug 01, 2021

Bourassa, L., Perchetti, G. A., Phung, Q., Lin, M. J., Mills, M. G., Roychoudhury, P., Harmon, K. G., Reed, J. C., & Greninger, A. L. (2021). A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance. Journal of Clinical Virology, 141, 104900. https://doi.org/10.1016/j.jcv.2021.104900

Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay

Journal of Clinical Virology / Jul 01, 2021

Perchetti, G. A., Pepper, G., Shrestha, L., LaTurner, K., Yae Kim, D., Huang, M.-L., Jerome, K. R., & Greninger, A. L. (2021). Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay. Journal of Clinical Virology, 140, 104869. https://doi.org/10.1016/j.jcv.2021.104869

Human Metapneumovirus Infection and Genotyping of Infants in Rural Nepal

Journal of the Pediatric Infectious Diseases Society / Nov 02, 2020

Perchetti, G. A., Wilcox, N., Chu, H. Y., Katz, J., Khatry, S. K., LeClerq, S. C., Tielsch, J. M., Jerome, K. R., Englund, J. A., & Kuypers, J. (2020). Human Metapneumovirus Infection and Genotyping of Infants in Rural Nepal. Journal of the Pediatric Infectious Diseases Society, 10(4), 408–416. https://doi.org/10.1093/jpids/piaa118

Pooling of SARS-CoV-2 samples to increase molecular testing throughput

Journal of Clinical Virology / Oct 01, 2020

Perchetti, G. A., Sullivan, K.-W., Pepper, G., Huang, M.-L., Breit, N., Mathias, P., Jerome, K. R., & Greninger, A. L. (2020). Pooling of SARS-CoV-2 samples to increase molecular testing throughput. Journal of Clinical Virology, 131, 104570. https://doi.org/10.1016/j.jcv.2020.104570

Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR

Journal of Clinical Virology / Aug 01, 2020

Perchetti, G. A., Nalla, A. K., Huang, M.-L., Jerome, K. R., & Greninger, A. L. (2020). Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR. Journal of Clinical Virology, 129, 104499. https://doi.org/10.1016/j.jcv.2020.104499

Phylogenetic characterization of rhinoviruses from infants in Sarlahi, Nepal

Journal of Medical Virology / Aug 21, 2019

Kuypers, J., Perchetti, G. A., Chu, H. Y., Newman, K. L., Katz, J., Khatry, S. K., LeClerq, S. C., Jerome, K. R., Tielsch, J. M., & Englund, J. A. (2019). Phylogenetic characterization of rhinoviruses from infants in Sarlahi, Nepal. Journal of Medical Virology, 91(12), 2108–2116. Portico. https://doi.org/10.1002/jmv.25563

2626. Rhinovirus in Children Presenting to the Emergency Department: Role of Viral Load in Disease Severity and Co-Infections

Open Forum Infectious Diseases / Oct 01, 2019

Waghmare, A., Strelitz, B., Lacombe, K., Perchetti, G., Nalla, A., Rha, B., Midgley, C., Lively, J. Y., Klein, E. J., Kuypers, J., & Englund, J. A. (2019). 2626. Rhinovirus in Children Presenting to the Emergency Department: Role of Viral Load in Disease Severity and Co-Infections. Open Forum Infectious Diseases, 6(Supplement_2), S915–S916. https://doi.org/10.1093/ofid/ofz360.2304

Large, Stable, Contemporary Interspecies Recombination Events in Circulating Human Herpes Simplex Viruses

The Journal of Infectious Diseases / Apr 23, 2019

Casto, A. M., Roychoudhury, P., Xie, H., Selke, S., Perchetti, G. A., Wofford, H., Huang, M.-L., Verjans, G. M. G. M., Gottlieb, G. S., Wald, A., Jerome, K. R., Koelle, D. M., Johnston, C., & Greninger, A. L. (2019). Large, Stable, Contemporary Interspecies Recombination Events in Circulating Human Herpes Simplex Viruses. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiz199

See Full Profile

Jeffrey Townsend

New Haven, CT
Professor of Biostatistics and Ecology & Evolutionary Biology
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (52)
Evolutionary Genomics
Microbiology
Genetics
Cell Biology
Ecology, Evolution, Behavior and Systematics
And 47 more
About
Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.
Most Relevant Publications (26+)

207 total publications

Horizontal gene transfer, genome innovation and evolution

Nature Reviews Microbiology / Aug 01, 2005

Gogarten, J. P., & Townsend, J. P. (2005). Horizontal gene transfer, genome innovation and evolution. Nature Reviews Microbiology, 3(9), 679–687. https://doi.org/10.1038/nrmicro1204

The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study

The Lancet Microbe / Dec 01, 2021

Townsend, J. P., Hassler, H. B., Wang, Z., Miura, S., Singh, J., Kumar, S., Ruddle, N. H., Galvani, A. P., & Dornburg, A. (2021). The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. The Lancet Microbe, 2(12), e666–e675. https://doi.org/10.1016/s2666-5247(21)00219-6

Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study

The Lancet HIV / Sep 01, 2018

Marshall, B. D. L., Goedel, W. C., King, M. R. F., Singleton, A., Durham, D. P., Chan, P. A., Townsend, J. P., & Galvani, A. P. (2018). Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. The Lancet HIV, 5(9), e498–e505. https://doi.org/10.1016/s2352-3018(18)30097-3

Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting

Journal of Medical Virology / Jan 18, 2023

Townsend, J. P., Hassler, H. B., & Dornburg, A. (2023). Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28461

Dogs and pigs are transport hosts of Necator americanus : Molecular evidence for a zoonotic mechanism of human hookworm transmission in Ghana

Zoonoses and Public Health / Jun 11, 2020

Boyko, R. H., Marie Harrison, L., Humphries, D., Galvani, A. P., Townsend, J. P., Otchere, J., Wilson, M. D., & Cappello, M. (2020). Dogs and pigs are transport hosts of Necator americanus  : Molecular evidence for a zoonotic mechanism of human hookworm transmission in Ghana. Zoonoses and Public Health, 67(5), 474–483. Portico. https://doi.org/10.1111/zph.12708

Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study

Clinical Infectious Diseases / May 30, 2019

Goedel, W. C., King, M. R. F., Lurie, M. N., Galea, S., Townsend, J. P., Galvani, A. P., Friedman, S. R., & Marshall, B. D. L. (2019). Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Clinical Infectious Diseases, 70(6), 1096–1102. https://doi.org/10.1093/cid/ciz321

The critical importance of retention in HIV prevention

The Lancet HIV / Sep 01, 2018

Golub, S. A., & Enemchukwu, C. U. (2018). The critical importance of retention in HIV prevention. The Lancet HIV, 5(9), e475–e476. https://doi.org/10.1016/s2352-3018(18)30130-9

Genomic Comparison Among Global Isolates of L. interrogans Serovars Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation Caused by an Indel

Frontiers in Cellular and Infection Microbiology / Jun 19, 2018

Santos, L. A., Adhikarla, H., Yan, X., Wang, Z., Fouts, D. E., Vinetz, J. M., Alcantara, L. C. J., Hartskeerl, R. A., Goris, M. G. A., Picardeau, M., Reis, M. G., Townsend, J. P., Zhao, H., Ko, A. I., & Wunder, E. A. (2018). Genomic Comparison Among Global Isolates of L. interrogans Serovars Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation Caused by an Indel. Frontiers in Cellular and Infection Microbiology, 8. https://doi.org/10.3389/fcimb.2018.00193

Lvr, a Signaling System That Controls Global Gene Regulation and Virulence in Pathogenic Leptospira

Frontiers in Cellular and Infection Microbiology / Feb 23, 2018

Adhikarla, H., Wunder, E. A., Mechaly, A. E., Mehta, S., Wang, Z., Santos, L., Bisht, V., Diggle, P., Murray, G., Adler, B., Lopez, F., Townsend, J. P., Groisman, E., Picardeau, M., Buschiazzo, A., & Ko, A. I. (2018). Lvr, a Signaling System That Controls Global Gene Regulation and Virulence in Pathogenic Leptospira. Frontiers in Cellular and Infection Microbiology, 8. https://doi.org/10.3389/fcimb.2018.00045

Cost-effectiveness of next-generation vaccines: The case of pertussis

Vaccine / Jun 01, 2016

Fitzpatrick, M. C., Wenzel, N. S., Scarpino, S. V., Althouse, B. M., Atkins, K. E., Galvani, A. P., & Townsend, J. P. (2016). Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine, 34(29), 3405–3411. https://doi.org/10.1016/j.vaccine.2016.04.010

Retrospective Analysis of the 2014–2015 Ebola Epidemic in Liberia

The American Journal of Tropical Medicine and Hygiene / Apr 06, 2016

Atkins, K. E., Nyenswah, T. G., Galvani, A. P., Bawo, L., Yamin, D., Altice, F. L., Fallah, M., Medlock, J., Skrip, L., Wenzel, N. S., Ndeffo-Mbah, M. L., Pandey, A., & Townsend, J. (2016). Retrospective Analysis of the 2014–2015 Ebola Epidemic in Liberia. The American Journal of Tropical Medicine and Hygiene, 94(4), 833–839. https://doi.org/10.4269/ajtmh.15-0328

Quantifying Transmission ofClostridium difficilewithin and outside Healthcare Settings

Emerging Infectious Diseases / Apr 01, 2016

Durham, D. P., Olsen, M. A., Dubberke, E. R., Galvani, A. P., & Townsend, J. P. (2016). Quantifying Transmission ofClostridium difficilewithin and outside Healthcare Settings. Emerging Infectious Diseases, 22(4), 608–616. https://doi.org/10.3201/eid2204.150455

Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis

PLOS Neglected Tropical Diseases / Mar 08, 2016

Gilbert, J. A., Medlock, J., Townsend, J. P., Aksoy, S., Ndeffo Mbah, M., & Galvani, A. P. (2016). Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. PLOS Neglected Tropical Diseases, 10(3), e0004465. https://doi.org/10.1371/journal.pntd.0004465

The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States

Clinical Infectious Diseases / Nov 30, 2015

Durham, D. P., Skrip, L. A., Bruce, R. D., Vilarinho, S., Elbasha, E. H., Galvani, A. P., & Townsend, J. P. (2015). The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clinical Infectious Diseases, 62(3), 298–304. https://doi.org/10.1093/cid/civ894

Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US

Vaccine / Jan 01, 2016

Alfaro-Murillo, J. A., Townsend, J. P., & Galvani, A. P. (2016). Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine, 34(2), 225–229. https://doi.org/10.1016/j.vaccine.2015.11.039

Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases

Parasites & Vectors / Dec 01, 2015

Hollingsworth, T. D., Adams, E. R., Anderson, R. M., Atkins, K., Bartsch, S., Basáñez, M.-G., Behrend, M., Blok, D. J., Chapman, L. A. C., Coffeng, L., Courtenay, O., Crump, R. E., de Vlas, S. J., Dobson, A., Dyson, L., Farkas, H., Galvani, A. P., Gambhir, M., … Zoueva, A. (2015). Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites & Vectors, 8(1). https://doi.org/10.1186/s13071-015-1235-1

Harnessing Case Isolation and Ring Vaccination to Control Ebola

PLOS Neglected Tropical Diseases / May 29, 2015

Wells, C., Yamin, D., Ndeffo-Mbah, M. L., Wenzel, N., Gaffney, S. G., Townsend, J. P., Meyers, L. A., Fallah, M., Nyenswah, T. G., Altice, F. L., Atkins, K. E., & Galvani, A. P. (2015). Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLOS Neglected Tropical Diseases, 9(5), e0003794. https://doi.org/10.1371/journal.pntd.0003794

Epidemiological and Viral Genomic Sequence Analysis of the 2014 Ebola Outbreak Reveals Clustered Transmission

Clinical Infectious Diseases / Dec 15, 2014

Scarpino, S. V., Iamarino, A., Wells, C., Yamin, D., Ndeffo-Mbah, M., Wenzel, N. S., Fox, S. J., Nyenswah, T., Altice, F. L., Galvani, A. P., Meyers, L. A., & Townsend, J. P. (2014). Epidemiological and Viral Genomic Sequence Analysis of the 2014 Ebola Outbreak Reveals Clustered Transmission. Clinical Infectious Diseases, 60(7), 1079–1082. https://doi.org/10.1093/cid/ciu1131

Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola

PLOS Neglected Tropical Diseases / Jun 24, 2015

Wells, C., Yamin, D., Ndeffo-Mbah, M. L., Wenzel, N., Gaffney, S. G., Townsend, J. P., Meyers, L. A., Fallah, M., Nyenswah, T. G., Altice, F. L., Atkins, K. E., & Galvani, A. P. (2015). Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLOS Neglected Tropical Diseases, 9(6), e0003888. https://doi.org/10.1371/journal.pntd.0003888

Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy

Epidemics / Mar 01, 2014

Gilbert, J. A., Meyers, L. A., Galvani, A. P., & Townsend, J. P. (2014). Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy. Epidemics, 6, 37–45. https://doi.org/10.1016/j.epidem.2013.11.002

Potential Cost-Effectiveness of Schistosomiasis Treatment for Reducing HIV Transmission in Africa – The Case of Zimbabwean Women

PLoS Neglected Tropical Diseases / Aug 01, 2013

Ndeffo Mbah, M. L., Poolman, E. M., Atkins, K. E., Orenstein, E. W., Meyers, L. A., Townsend, J. P., & Galvani, A. P. (2013). Potential Cost-Effectiveness of Schistosomiasis Treatment for Reducing HIV Transmission in Africa – The Case of Zimbabwean Women. PLoS Neglected Tropical Diseases, 7(8), e2346. https://doi.org/10.1371/journal.pntd.0002346

Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty

Vaccine / Jun 01, 2013

Ndeffo Mbah, M. L., Medlock, J., Meyers, L. A., Galvani, A. P., & Townsend, J. P. (2013). Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine, 31(30), 3079–3089. https://doi.org/10.1016/j.vaccine.2013.04.052

Reevaluation of Epidemiological Data Demonstrates That It Is Consistent With Cross-Immunity Among Human Papillomavirus Types

Journal of Infectious Diseases / Aug 07, 2012

Durham, D. P., Poolman, E. M., Ibuka, Y., Townsend, J. P., & Galvani, A. P. (2012). Reevaluation of Epidemiological Data Demonstrates That It Is Consistent With Cross-Immunity Among Human Papillomavirus Types. Journal of Infectious Diseases, 206(8), 1291–1298. https://doi.org/10.1093/infdis/jis494

Potential for Rabies Control through Dog Vaccination in Wildlife-Abundant Communities of Tanzania

PLoS Neglected Tropical Diseases / Aug 21, 2012

Fitzpatrick, M. C., Hampson, K., Cleaveland, S., Meyers, L. A., Townsend, J. P., & Galvani, A. P. (2012). Potential for Rabies Control through Dog Vaccination in Wildlife-Abundant Communities of Tanzania. PLoS Neglected Tropical Diseases, 6(8), e1796. https://doi.org/10.1371/journal.pntd.0001796

Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures

Journal of Antimicrobial Chemotherapy / Jan 07, 2011

Johnsen, P. J., Townsend, J. P., Bohn, T., Simonsen, G. S., Sundsfjord, A., & Nielsen, K. M. (2011). Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures. Journal of Antimicrobial Chemotherapy, 66(3), 608–610. https://doi.org/10.1093/jac/dkq512

Factors affecting the reversal of antimicrobial-drug resistance

The Lancet Infectious Diseases / Jun 01, 2009

Johnsen, P. J., Townsend, J. P., Bøhn, T., Simonsen, G. S., Sundsfjord, A., & Nielsen, K. M. (2009). Factors affecting the reversal of antimicrobial-drug resistance. The Lancet Infectious Diseases, 9(6), 357–364. https://doi.org/10.1016/s1473-3099(09)70105-7

See Full Profile

Liam D. Hendrikse, Ph.D.

Toronto, Ontario, Canada
Bioinformatician at the University Health Network in Toronto, CA, specializing in computational cancer research using various sequencing modalities.
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (7)
Medulloblastoma
Bioinformatics
Genomics
Oncology
Virology
And 2 more
About
Liam Hendrikse is a recent Ph.D. graduate from the Department of Medical Biophysics at the University of Toronto, now working as a Bioinformatician at the University Health Network. His research focuses on deepening our understanding of various cancer types using computational methods, in order to develop novel treatment options. Liam has a particular strength in analysis of various single-cell sequencing technologies (RNA, ATAC, CITE, TCR/BCR, etc.), as well as traditional sequencing technologies, such as bulk RNAseq. Liam has a proven track record of deriving highly impactful biological insights through his research, as evidenced by publications in high impact journals such as Nature and Cancer Discovery. Previously, Liam earned his Bachelor of Science in biochemistry and immunology from Western University in 2018.
Most Relevant Publications (1+)

10 total publications

Identification of a Novel Gammaherpesvirus in Canada lynx (Lynx canadensis)

Viruses / Apr 20, 2019

Hendrikse, L. D., Kambli, A., Kayko, C., Canuti, M., Rodrigues, B., Stevens, B., Vashon, J., Lang, A. S., Needle, D. B., & Troyer, R. M. (2019). Identification of a Novel Gammaherpesvirus in Canada lynx (Lynx canadensis). Viruses, 11(4), 363. https://doi.org/10.3390/v11040363

See Full Profile

Abbas Alameer

Assistant Professor of Bioinformatics at Kuwait University
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (10)
Bioinformatics
Computational Mathematics
Computational Theory and Mathematics
Computer Science Applications
Molecular Biology
And 5 more
About
Abbas Alameer is an Assistant Professor of Bioinformatics at Kuwait University. He received his PhD in Bioinformatics and Molecular Modelling from the University of Leicester in 2014 and his MRes in Bioinformatics and Computational Biology from the University of Leeds in 2006. He has over 10 years of experience in bioinformatics related research and teaching. His research focuses on the computational analysis and modelling of biological molecules, and the development of novel algorithms and Bioinformatics tools. He has published several articles in leading journals in the field and has presented his work at international conferences.
Most Relevant Publications (1+)

3 total publications

Whole-Genome and Targeted-Amplicon Sequencing of Fluconazole-Susceptible and -Resistant Candida parapsilosis Isolates from Kuwait Reveals a Previously Undescribed N1132D Polymorphism in CDR1

Antimicrobial Agents and Chemotherapy / Jan 20, 2021

Asadzadeh, M., Dashti, M., Ahmad, S., Alfouzan, W., & Alameer, A. (2021). Whole-Genome and Targeted-Amplicon Sequencing of Fluconazole-Susceptible and -Resistant Candida parapsilosis Isolates from Kuwait Reveals a Previously Undescribed N1132D Polymorphism in CDR1. Antimicrobial Agents and Chemotherapy, 65(2). https://doi.org/10.1128/aac.01633-20

See Full Profile

Naveen Adusumilli

Warner Bruner Endowed Professor, Associate Professor- Extension Economist -Louisiana State University
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (29)
Soil and Water Policy
Production Economics
Agronomy and Crop Science
Earth-Surface Processes
Water Science and Technology
And 24 more
About
Naveen Adusumilli is an accomplished agricultural economist with a strong background in conservation policy-related research and extension work. He completed his PhD in Agricultural Economics from Texas A&M University in 2012, focusing on the economics of water resource management in agriculture. During his doctoral studies, he conducted extensive research on the impacts of climate change on agricultural production and the role of water markets in mitigating these impacts. After completing his PhD, Naveen joined Louisiana State University as an Extension Economist. In this role, he worked closely with farmers, policymakers, and other stakeholders to provide economic analysis and recommendations for improving agricultural productivity and sustainability. He also conducted outreach programs to educate farmers about the latest research findings and best practices in the field of agricultural economics. Naveen's research has been published in numerous peer-reviewed journals, and he has presented at more than 100 farmer group meetings and national and international conferences. He has also received several awards and grants for his research contributions, including the Emerging Scholars Award in 2017 from the Southern Agricultural Economics Association and, in 2021, the Chair Leadership Award for his contributions to Soil and Water Conservation Society. from the Agricultural and Applied Economics Association. In addition to his work in academia, Naveen has also collaborated with various government agencies and international organizations on projects related to agricultural development and resource management. His expertise in agricultural economics has been sought after by organizations such as the Foundation for Agricultural Research, the National Institute for Water Resources, Foreign Agricultural Services, the Natural Resources Conservation Service, the Food and Agriculture Organization of the United Nations, and the World Bank. Naveen is a dedicated and passionate economist who is committed to finding solutions for the complex challenges facing the agricultural industry. Through his research and extension work, he continues to make valuable contributions to the field of agricultural economics and drive positive change in the world of farming.
Most Relevant Publications (1+)

35 total publications

Estimating effects of improved drinking water and sanitation on cholera

Journal of Water and Health / Aug 23, 2013

Leidner, A. J., & Adusumilli, N. C. (2013). Estimating effects of improved drinking water and sanitation on cholera. Journal of Water and Health, 11(4), 671–683. https://doi.org/10.2166/wh.2013.238

See Full Profile

Javier O. Morales

Professor of drug delivery and pharmaceutical product development at University of Chile
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (30)
Pharmaceutics
Biotechnology
Pharmaceutical Science
Drug Discovery
Agronomy and Crop Science
And 25 more
About
Javier O. Morales is a highly accomplished and experienced pharmaceutical professional with a strong academic background and extensive practical experience. He obtained his Bachelor of Science degree in Pharmacy in 2006 and the Pharmaceutical Chemist degree in 2008 from the University of Chile. He then went on to obtain his Ph.D. in Pharmaceutics from The University of Texas at Austin in 2012. Dr. Morales has since worked as an Assistant Professor and later as an Associate Professor at the University of Chile. He has also served as the Director of the Center of New Drugs for Hypertension (CENDHY), where he led a team of researchers in developing new and innovative pharmaceutical treatments for hypertension. Dr. Morales has a strong passion for research and has published numerous articles in international journals and has patented his developed technologies. His expertise in pharmaceuticals, nano and microstructured drug delivery systems, implants, and peptide drug discovery has made him a sought-after speaker at conferences and symposiums around the world. In addition to his academic and research achievements, Dr. Morales is also a dedicated mentor and has supervised and mentored several students in their research projects. He is known for his commitment to excellence and his ability to motivate and inspire others. Overall, Dr. Morales is a highly respected and accomplished pharmaceutical professional with a strong track record of success in academia. His contributions to the field of pharmaceutical sciences have made a significant impact, and he continues to be a leader in the industry.
Most Relevant Publications (3+)

63 total publications

Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems

Vaccines / Oct 14, 2021

Trincado, V., Gala, R. P., & Morales, J. O. (2021). Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems. Vaccines, 9(10), 1177. https://doi.org/10.3390/vaccines9101177

Nanoparticles as Potential Novel Therapies for Urinary Tract Infections

Frontiers in Cellular and Infection Microbiology / Apr 19, 2021

Sánchez, S. V., Navarro, N., Catalán-Figueroa, J., & Morales, J. O. (2021). Nanoparticles as Potential Novel Therapies for Urinary Tract Infections. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.656496

Poly-ε-caprolactone Nanoparticles Loaded with 4-Nerolidylcatechol (4-NC) for Growth Inhibition of Microsporum canis

Antibiotics / Dec 11, 2020

Greatti, V. R., Oda, F., Sorrechia, R., Kapp, B. R., Seraphim, C. M., Weckwerth, A. C. V. B., Chorilli, M., Silva, P. B. D., Eloy, J. O., Kogan, M. J., Morales, J. O., & Pietro, R. C. L. R. (2020). Poly-ε-caprolactone Nanoparticles Loaded with 4-Nerolidylcatechol (4-NC) for Growth Inhibition of Microsporum canis. Antibiotics, 9(12), 894. https://doi.org/10.3390/antibiotics9120894

See Full Profile

Odion Ikhimiukor

Postdoctoral Research Scientist at University at Albany, State University of New York
Most Relevant Research Expertise
Infectious Diseases
Other Research Expertise (23)
Pathogen Genomics
Bioinformatics
Molecular Biology
Epidemiology
Environmental Microbiology
And 18 more
About
A postdoctoral research scientist with over 9 years experience in bacterial genomics, microbiology, bioinformatics and antimicrobial resistance research. I’m seeking a Research Scientist or Epidemiologist role at public health genomics laboratories and I am the perfect fit for these roles because I have the following skills: molecular biology, research & development, strategic planning, project management, documentation, outbreak investigation, and cross-functional collaboration skills. I have leveraged my skills to work in a collaborative team-oriented environment to accomplish project goals related to examining the evolution of antimicrobial resistance as evidenced by over 7 national and international collaborations including the New York State Department of Health. I am also a proactive problem-solver adopting innovative and scientific thinking strategies in molecular biology to fulfill project objectives resulting in scientific discoveries including uncovering 1 novel hotspot for the dissemination of resistance in bacteria. I have gained mentorship expertise in promoting data reproducibility, and innovative research methodology in antimicrobial resistance research as evidenced by mentoring 10 professionals on evolutionary genomics, epidemiological statistics, and antimicrobial stewardship. I have also worked collaboratively with a team to apply pathogen genomics, bioinformatics, and leadership skills as demonstrated by working with over 10 highly collaborative teams including the Africa CDC. In addition, I have the following qualifications: Cross-functional collaborator and experience elucidating methods and frequencies of horizontal gene transfer and antimicrobial resistance spread in bacterial species, as demonstrated by 26 peer-reviewed publications including 1 in Nature Microbiology. Experience in leading and managing project details and tasks as evidenced by over 20 projects in pathogen genomics, epidemiology, antimicrobial resistance surveillance, and global health. Astute communication skills in bacterial epidemiology and antimicrobial resistance research resulting in 20 presentations and 6 travel awards to deliver such presentations, including the Bill and Melinda Gates Foundation. I want to serve an organization that prizes community, collaboration and humility among its employees. I’m excited to be on a team built around impact, innovation and a strong, positive reputation. I know I will thrive at a company where responsibility is valued, as well as self-improvement and time-management. I want to be a part of an organization that infuses growth into their brand, culture and market and who I can help make a difference in the world.
Most Relevant Publications (3+)

27 total publications

Phylogenetic lineages and antimicrobial resistance determinants of clinical Klebsiella oxytoca spanning local to global scales

Microbiology Spectrum / Oct 17, 2023

Ikhimiukor, O. O., Souza, S. S. R., Akintayo, I. J., Marcovici, M. M., Workman, A., Martin, I. W., & Andam, C. P. (2023). Phylogenetic lineages and antimicrobial resistance determinants of clinical Klebsiella oxytoca spanning local to global scales. Microbiology Spectrum, 11(5). https://doi.org/10.1128/spectrum.00549-23

A snapshot survey of antimicrobial resistance in food-animals in low and middle-income countries

One Health / Jun 01, 2023

Ikhimiukor, O. O., & Okeke, I. N. (2023). A snapshot survey of antimicrobial resistance in food-animals in low and middle-income countries. One Health, 16, 100489. https://doi.org/10.1016/j.onehlt.2023.100489

Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria

PLOS Neglected Tropical Diseases / Aug 26, 2022

Ikhimiukor, O. O., Oaikhena, A. O., Afolayan, A. O., Fadeyi, A., Kehinde, A., Ogunleye, V. O., Aboderin, A. O., Oduyebo, O. O., Elikwu, C. J., Odih, E. E., Komolafe, I., Argimón, S., Egwuenu, A., Adebiyi, I., Sadare, O. A., Okwor, T., Kekre, M., Underwood, A., Ihekweazu, C., … Okeke, I. N. (2022). Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria. PLOS Neglected Tropical Diseases, 16(8), e0010716. https://doi.org/10.1371/journal.pntd.0010716

See Full Profile

Example infectious diseases projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on infectious diseases?

Vaccine Development

An academic researcher in Infectious Diseases can contribute to the development of vaccines for various infectious diseases. Their expertise in understanding the mechanisms of pathogens and the immune system can help in designing effective vaccines.

Drug Discovery

Collaborating with an Infectious Diseases expert can aid in the discovery of new drugs and therapies to combat infectious diseases. Their knowledge of disease mechanisms and drug targets can accelerate the development of effective treatments.

Epidemiological Studies

Academic researchers in Infectious Diseases can conduct epidemiological studies to understand the spread and impact of infectious diseases. This data can help companies in developing strategies for disease prevention and control.

Diagnostic Test Development

Working with an expert in Infectious Diseases can assist in the development of accurate and efficient diagnostic tests for infectious diseases. Their understanding of disease markers and detection methods can improve testing capabilities.

Public Health Policy

Collaboration with an academic researcher in Infectious Diseases can provide valuable insights for shaping public health policies. Their expertise can contribute to evidence-based decision-making and effective disease control measures.